Common Contracts
38 similar Research and License Agreement contracts by Kosan Biosciences Inc, Arqule Inc, Combinatorx, Inc, others
Exhibit 10.1 RESEARCH AND LICENSE AGREEMENT This License Agreement is entered into as of this 30th day of March, 2006 (the "Restated Effective Date"), by and between Brainstorm Cell Therapeutics Inc.(formerly Golden Hand Resources, Inc.), a company...Research and License Agreement • April 4th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
BETWEENResearch and License Agreement • March 20th, 2006 • Combinatorx, Inc • Pharmaceutical preparations • New York
EXHIBIT 10.46 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS([**]), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED...Research and License Agreement • October 5th, 2005 • Combinatorx, Inc • Pharmaceutical preparations • New York
Exhibit 10.7 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SPONSORED RESEARCH AND LICENSE AGREEMENT BETWEENResearch and License Agreement • May 25th, 2004 • Critical Therapeutics Inc • Pharmaceutical preparations • New York
Exhibit 10.7 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SPONSORED RESEARCH AND LICENSE AGREEMENT BETWEENResearch and License Agreement • March 19th, 2004 • Critical Therapeutics Inc • New York
EXHIBIT NO. 10.8 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. RESEARCH AND LICENSE AGREEMENT This Agreement is effective June 1, 1993 ("the EFFECTIVE DATE") by and between...Research and License Agreement • August 20th, 2003 • Nitromed Inc • Massachusetts
RECITALSResearch and License Agreement • November 20th, 2002 • Neogenomics Inc • Services-commercial physical & biological research • California
AMENDMENTResearch and License Agreement • July 30th, 2002 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances
RESEARCH AND LICENSE AGREEMENT This Agreement, dated as of 02 August 2001 (the "Effective Date"), is by and between Research and Diagnostic Systems, Inc., a Minnesota corporation with principal offices at 614 McKinley Place NE, Minneapolis, Minnesota...Research and License Agreement • September 27th, 2001 • Techne Corp /Mn/ • Biological products, (no disgnostic substances) • Minnesota
Exhibit 10.8 RESEARCH AND LICENSE AGREEMENT This Agreement is effective April 5, 1994 ("the EFFECTIVE DATE") by and between Stem Cell Sciences Pty Ltd (ACN 063 293 130), 420 St. Kilda Road, Melbourne, 3004, Victoria, Australia ("SCS"), and...Research and License Agreement • March 12th, 2001 • Biotransplant Inc • Pharmaceutical preparations • Victoria
1 EXHIBIT 10.36 RESEARCH AND LICENSE AGREEMENT DATED OCTOBER 26, 2000Research and License Agreement • November 16th, 2000 • Array Biopharma Inc • Services-medical laboratories • Colorado
EXHIBIT 10.11 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • October 4th, 2000 • Kosan Biosciences Inc • Services-commercial physical & biological research • California
EXHIBIT 10.11 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • September 28th, 2000 • Kosan Biosciences Inc • Services-commercial physical & biological research • California
BETWEENResearch and License Agreement • September 7th, 2000 • Kosan Biosciences Inc • Services-commercial physical & biological research • New York
Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] RESEARCH AND LICENSE AGREEMENT This License Agreement ("Agreement"), effective as of 28th day of May, 1999...Research and License Agreement • August 14th, 2000 • New Brunswick Scientific Co Inc • Laboratory apparatus & furniture
EXHIBIT 10.11 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • August 8th, 2000 • Kosan Biosciences Inc • Services-commercial physical & biological research • California
EXHIBIT 10.11 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • March 31st, 2000 • Kosan Biosciences Inc • California
Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] RESEARCH AND LICENSE AGREEMENT This License Agreement ("Agreement"), effective as of 28th day of May, 1999...Research and License Agreement • August 16th, 1999 • New Brunswick Scientific Co Inc • Laboratory apparatus & furniture
ANDResearch and License Agreement • August 3rd, 1999 • Lexon Inc/Ok
ASTRA AB ANDResearch and License Agreement • March 24th, 1999 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 10.28 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AMENDED AND RESTATED RESEARCH AND LICENSE AGREEMENT (Incorporating amendments to the Research and License...Research and License Agreement • March 24th, 1999 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
RECITALSResearch and License Agreement • March 17th, 1999 • Axonyx Inc
1 Exhibit 10.1 AMENDMENT NO. 1 TO RESEARCH AND LICENSE AGREEMENT This Amendment No. 1, dated as of September 30, 1998 is between ArQule, Inc. ("ArQule") a Delaware Corporation and Roche Bioscience, a division of Syntex (U.S.A.) Inc. ("Roche...Research and License Agreement • November 16th, 1998 • Arqule Inc • Pharmaceutical preparations
RECITALSResearch and License Agreement • May 19th, 1998 • Hypertension Diagnostics Inc /Mn
RESEARCH AND LICENSE AGREEMENT between BIOCHEM PHARMA, INC. and SCRIPTGEN PHARMACEUTICALS, INC. December 12, 1997Research and License Agreement • February 3rd, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • New York
RESEARCH AND LICENSE AGREEMENT between BIOCHEM PHARMA, INC. and SCRIPTGEN PHARMACEUTICALS, INC. December 12, 1997Research and License Agreement • January 8th, 1998 • Scriptgen Pharmaceuticals Inc • Pharmaceutical preparations • New York
TABLE OF CONTENTSResearch and License Agreement • October 17th, 1997 • Vysis Inc • New York
EXHIBIT 10.23 AMENDED RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • October 9th, 1997 • Cell Pathways Inc • Arizona
NYU/SUGENResearch and License Agreement • August 14th, 1997 • Sugen Inc • Biological products, (no disgnostic substances)
1 RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • August 12th, 1997 • Arqule Inc • Pharmaceutical preparations • Massachusetts
ANDResearch and License Agreement • May 15th, 1997 • Oncogene Science Inc • In vitro & in vivo diagnostic substances • New York
ANDResearch and License Agreement • March 31st, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Indiana
EXHIBIT 10.65 PORTIONS OF THE FOLLOWING DOCUMENT HAVE DELETED DUE TO THE CONFIDENTIAL NATURE OF THE INFORMATION CONTAINED THEREIN. SUCH DELETIONS ARE INDICATED AS FOLLOWS: (CONFIDENTIAL TREATMENT HAS BEEN REQUESTED) THE CONFIDENTIAL INFORMATION HAS...Research and License Agreement • March 27th, 1997 • Medimmune Inc /De • Biological products, (no disgnostic substances)
AMENDMENTResearch and License Agreement • February 21st, 1997 • Nymox Pharmaceutical Corp • In vitro & in vivo diagnostic substances
RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • February 10th, 1997 • Synaptic Pharmaceutical Corp • Services-commercial physical & biological research • New York
